20.02.2013 Views

Drug Targeting Organ-Specific Strategies

Drug Targeting Organ-Specific Strategies

Drug Targeting Organ-Specific Strategies

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3.9 Inspiratory Pressure and Relevant Flow Parameters 75<br />

where Φ V is the volumetric flow rate, ρ A is the density of the air (upstream of the flow constriction)<br />

and Fu(A) is a function of the cross-section of the flow constriction. Several authors<br />

use a simplification of this formula, written in terms of driving force (√∆P), airflow resistance<br />

(R E) and volumetric airflow (Φ V) (e.g. references [22,100]).<br />

√∆P = R E x Φ V<br />

(3.2a)<br />

In this equation, R E is the reciprocal of Fu(A) x √(2/ρ A). If there is no interaction between<br />

the flow through the inhaler and the flow in the respiratory tract, total resistance (R TOT) may<br />

be written as R TOT 2 = RI 2 + RE 2 . It has been reported that a high external resistance influences<br />

the shape and width of the human pharynx and larynx in a manner favourable for deep<br />

lung deposition [101].<br />

The resistance of dry powder inhalers can be calculated by measuring the volumetric flow<br />

rate and the pressure drop across the device simultaneously and applying Eq. 3.2a for the calculation.<br />

Values for some marketed DPIs are given in Table 3.7, showing that there are remarkable<br />

differences between devices.<br />

Table 3.7. Airflow resistances of some marketed dry powder inhalers in kPa 0.5 min l –1 .<br />

Reference [100] [144] [145] Mean<br />

Glaxo Rotahaler 0.013 0.013 0.014 0.0133<br />

Fisons Spinhaler 0.016 0.015 0.015 0.0153<br />

Pharbita Cyclohalera 0.017 0.018 0.018 0.0177<br />

Sofotec Novolizer – – 0.026 0.0260<br />

Glaxo Diskhalerc 0.021 0.018 0.030 0.0230<br />

Glaxo Diskus – – 0.032 0.0320<br />

Astra Turbuhaler 0.031 0.039 0.040 0.0367<br />

Inhalator Ingelheimb 0.056 0.053 0.048–0.058 0.0540<br />

Chiesi Inhaler – 0.093 – 0.0930<br />

a Also known as ISF inhaler and Novartis (Foradil) Inhaler.<br />

b The range in reference [145] is a consequence of poor reproducibility in capsule piercing.<br />

c The spread for the Glaxo Diskhaler may come from the use of two different devices: four-dose [145]<br />

and eight-dose [100, 144].<br />

1 technical bar equals 1000 mbar = 105 Pa (N m-2 or kg s-2 m-1 ) = 102 kPa<br />

Resistances have been (re-)calculated for standard liters per minute (at 20 °C: LS min-1 =<br />

1,0733*LN min –1 ).<br />

3.9 Inspiratory Pressure and Relevant Flow Parameters<br />

Several authors measured attainable pressure drops as a function of the external resistance<br />

for different groups of volunteers. Healthy male subjects (during maximal inspiration) are<br />

able to create a pressure drop (on average) of 6.7 kPa through an airflow resistance of<br />

0.038 kPa 0.5 min l –1 , (which is in the range of that of marketed DPIs, see Table 3.7), whereas<br />

females are able to create a pressure drop of 3.8 kPa under the same resistance [22]. Differences<br />

between different groups of patients depend on the degree to which pulmonary func-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!